Anthrax Lethal Factor
From Proteopedia
(Difference between revisions)
(29 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load=' | + | <StructureSection load='1j7n' size='340' side='right' scene='' caption='Anthrax toxin lethal factor dimer complex with sulfate and Zn+2 ions (grey) [[1j7n]]'> |
+ | __TOC__ | ||
==Introduction== | ==Introduction== | ||
---------------- | ---------------- | ||
- | Lethal Factor (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, protective antigen (PA) and two enzyme components edema factor (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref> | + | '''Anthrax Lethal Factor''' (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, [[Anthrax protective antigen|protective antigen]] (PA) and two enzyme components [[Anthrax edema factor|edema factor]] (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref> See also [[Toxins]]. |
Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref> | Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref> | ||
- | EF is a calmodulin and calcium dependent adenylate cyclase that increases cAMP to extraordinary levels in | + | EF is a calmodulin and calcium dependent adenylate cyclase that increases cAMP to extraordinary levels in cells. Changes in intracellular cAMP affect membrane permeability and may account for edema. In macrophages and neutrophils an additional effect is the depletion of ATP reserves which are needed for the engulfment process. <ref name=Collier>PMID: 14570563</ref> <ref name=Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC>PMID: 11700563</ref> <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> |
LF is a Zinc dependent protease that cleaves certain MAP kinase kinases (MAPKK)leading to the disruption of many cellular signalling pathways, which eventually leads to cell death. <ref name=Collier>PMID: 14570563</ref> <ref name=Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC>PMID: 11700563</ref> | LF is a Zinc dependent protease that cleaves certain MAP kinase kinases (MAPKK)leading to the disruption of many cellular signalling pathways, which eventually leads to cell death. <ref name=Collier>PMID: 14570563</ref> <ref name=Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC>PMID: 11700563</ref> | ||
Line 22: | Line 23: | ||
PA+LF+EF Leads to lethal activity and edema | PA+LF+EF Leads to lethal activity and edema | ||
+ | |||
+ | See also [[Anthrax Lethal Factor (hebrew)]]. | ||
==Human Interaction== | ==Human Interaction== | ||
Line 36: | Line 39: | ||
==Treatments== | ==Treatments== | ||
- | Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are Ciprofloxacin and Doxycycline. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>. | + | Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are [[Ciprofloxacin]] and [[Doxycycline]]. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>. |
Line 60: | Line 63: | ||
----------------------------- | ----------------------------- | ||
- | The MAPKK family of proteins are the only known cellular substrates of LF. LF cleaves near their N termini removing the docking sequence for the downstream MAP kinase | + | The MAPKK family of proteins are the only known cellular substrates of LF. LF cleaves near their N termini removing the docking sequence for the downstream MAP kinase. At low levels of LF, MAPKK-3 is cleaved inhibiting release of pro-inflammatory mediators. In contrast, high levels of LF lead to lysis of macrophages within a few hours, by an unknown mechanism. This suggests during early infection there is a delayed immune response while in the late stage of infection bacterium in the bloodstream trigger macrophage lysis and the sudden release of high levels pro-inflammatory mediators. This is consistent with the septic shock symptoms seen before death. <ref name=Collier>PMID: 14570563</ref> <ref name=Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC>PMID: 11700563</ref> |
<scene name='Anthrax_Lethal_Factor/Domain_4_active_site/2'>Active Site</scene> | <scene name='Anthrax_Lethal_Factor/Domain_4_active_site/2'>Active Site</scene> | ||
Line 70: | Line 73: | ||
The most will known case of biological warfare in recent times occurred in 2001, known as [http://en.wikipedia.org/wiki/2001_anthrax_attacks Amerithrax]. Anthrax spores are a top choice for biological warfare because their potency. Production of these spores are among the easiest of bioterror agents. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> They can be manipulated and produced in large quantities using basic microbiology techniques. Naturally occurring spores tend to aggregate making them less infection; they can easily be refined and dispersed. Because the anthrax spores are very robust; being able to survive for decades and are difficult to destroy, makes them excellent bioweapons. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> | The most will known case of biological warfare in recent times occurred in 2001, known as [http://en.wikipedia.org/wiki/2001_anthrax_attacks Amerithrax]. Anthrax spores are a top choice for biological warfare because their potency. Production of these spores are among the easiest of bioterror agents. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> They can be manipulated and produced in large quantities using basic microbiology techniques. Naturally occurring spores tend to aggregate making them less infection; they can easily be refined and dispersed. Because the anthrax spores are very robust; being able to survive for decades and are difficult to destroy, makes them excellent bioweapons. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> | ||
+ | == 3D structures of anthrax lethal factor== | ||
+ | [[Anthrax lethal factor 3D structures]] | ||
+ | |||
+ | </StructureSection> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
- | + | ||
+ | |||
+ | [[Category:Topic Page]] |
Current revision
|
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol. 2003;19:45-70. PMID:14570563 doi:10.1146/annurev.cellbio.19.111301.140655
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
- ↑ CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
- ↑ Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009 Dec;30(6):439-55. Epub 2009 Jul 26. PMID:19638283 doi:10.1016/j.mam.2009.07.003
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
- ↑ Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html